Merge makes move to explore sale

Lisa Fratt | | Health Exec | Digital Transformation
money, question mark - 82.89 Kb
Merge Healthcare has retained Allen & Company, an investment bank, to assist in exploring and evaluating a range of strategic alternatives, including, but not limited to, a sale of the company or a business combination.

Merge, which is based in Chicago, does not have a definitive timeline for the strategic review, and there can be no assurance that the review will result in any specific action or transaction, according to a company statement.

The developer of enterprise imaging and interoperability technologies delved further into the imaging informatics space in April 2010 with the acquisition of PACS giant Amicas. Following that merger, Merge posted a net loss of nearly $31 million in 2010, which the company partly attributed to the acquisition costs.

Despite posting continued sales growth, the company reported a net loss of $10 million for the fiscal year of 2011 and a net loss of $5.9 million in second quarter 2012.

Lisa Fratt

Related Content

AdvaMed itemizes AI imperatives for ‘the entire healthcare ecosystem’
6 things high-achieving orgs do to wring real value from AI
A modest proposal to rally AI regulators around a simple game plan
4 points crucial to the nimble regulation of GenAI
5 tips to learn AI from scratch and for free
Good AI governance can spell the difference between smashing success and mere learning experience

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup